Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Xiaoyan SI"'
Autor:
Ziyue Zhou, Xiaoxiang Zhou, Xu Jiang, Bo Yang, Xin Lu, Yunyun Fei, Lidan Zhao, Hua Chen, Li Zhang, Xiaoyan Si, Naixin Liang, Yadong Wang, Dan Yang, Yezi Peng, Yiying Yang, Zhuoran Yao, Yangzhige He, Xunyao Wu, Wen Zhang, Min Wang, Huaxia Yang, Xuan Zhang
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Inflammatory arthritis (IA) is a common rheumatic adverse event following immune checkpoint inhibitors treatment. The clinical disparities between IA and rheumatoid arthritis (RA) imply disease heterogeneity and distinct mechanisms, which re
Externí odkaz:
https://doaj.org/article/3ffeb63f8198439fb1853b557d07b564
Publikováno v:
Veterinary Medicine and Science, Vol 9, Iss 5, Pp 2201-2211 (2023)
Abstract Background The frequent interactions of rodents with humans make them a common source of zoonotic infections. Brandt's vole is the dominant rodent species of the typical steppe in Inner Mongolia, and it is also an important pest in grassland
Externí odkaz:
https://doaj.org/article/24e2b4bfb2b74c01adf56895fe771966
Autor:
Xiaoyan Si, Xueqing Zheng, Xinlun Tian, Hanping Wang, Yan Xu, Jing Zhao, Minjiang Chen, Wei Zhong, Mengzhao Wang, Li Zhang, Xiaotong Zhang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 21, Pp 2038-2044 (2023)
Abstract Background The discovery of immune checkpoint inhibitors (ICIs) is a breakthrough in the field of cancer therapy. However, ICIs may cause immune‐related adverse reactions, including checkpoint inhibitor‐related pneumonitis (CIP). The aim
Externí odkaz:
https://doaj.org/article/ec91e25e49c948a4ab5d9abb42e1647e
Publikováno v:
Thoracic Cancer, Vol 14, Iss 13, Pp 1162-1170 (2023)
Abstract Background The c‐MET protein, encoded by the mesenchymal‐epithelial transition factor (MET) gene, can regulate cell proliferation, migration and invasion. Studies have shown that it is one of the essential driver genes for non‐small ce
Externí odkaz:
https://doaj.org/article/6db5f277803549c4ad1ab36ac70aff15
Autor:
Jing Zhao, Yang Wu, Yuan Yue, Minjiang Chen, Yan Xu, Xiangning Liu, Xiaoyan Liu, Xiaoxing Gao, Hanping Wang, Xiaoyan Si, Wei Zhong, Xiaotong Zhang, Li Zhang, Mengzhao Wang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 5, Pp 497-505 (2023)
Abstract Background Immune checkpoint inhibitors (ICIs) have become one important therapeutic strategy for advanced non‐small‐cell lung cancer (NSCLC). It remains imperative to identify reliable and convenient biomarkers to predict both the effic
Externí odkaz:
https://doaj.org/article/56b3c9c16b634f28bb0a279bd5b01767
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 1, Iss 1, Pp 18-24 (2023)
Background: Small cell lung cancer (SCLC) is a highly malignant and aggressive neuroendocrine tumor. With the rise of immunotherapy, it has provided a new direction for SCLC. However, due to the lack of prognostic biomarkers, the median overall survi
Externí odkaz:
https://doaj.org/article/5a70c272c0294401856d3fe75b8a153f
Publikováno v:
Cancer Innovation, Vol 1, Iss 4, Pp 344-347 (2022)
Abstract Pyrotinib is a novel human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitor (TKI). Previous studies of pyrotinib showed that it is mainly excreted through the gastrointestinal tract rather than the kidneys, with little eff
Externí odkaz:
https://doaj.org/article/f6f58b1465624f5087361b9c5ff395f6
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundProgrammed cell death-ligand 1 (PD-L1) inhibitors plus chemotherapy have made substantial progress in extensive-stage small-cell lung cancer (ES-SCLC), but the survival benefit is still limited. This study aimed to evaluate the preliminary
Externí odkaz:
https://doaj.org/article/67924a8ae3224d5d9a4eb59d2540093a
Autor:
Xiaoxing Gao, Ruili Pan, Minjiang Chen, Jing Zhao, Wei Zhong, Hanping Wang, Xiaoyan Si, Xiaotong Zhang, Li Zhang, Yan Xu, Mengzhao Wang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 7, Pp 1059-1066 (2022)
Abstract Background To investigate the prognostic value of magnetic resonance imaging (MRI) findings in the prognosis of patients with leptomeningeal metastasis from lung adenocarcinoma. Methods Patients with lung adenocarcinoma complicated with cyto
Externí odkaz:
https://doaj.org/article/f72a52fb918d4b98ac319cee30f7c275
Autor:
Jun Ni, Xiaotong Zhang, Hanping Wang, Xiaoyan Si, Yan Xu, Jing Zhao, Minjiang Chen, Li Zhang, Mengzhao Wang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 4, Pp 539-548 (2022)
Abstract Background Small cell lung cancer (SCLC) is a highly aggressive neuroendocrine tumor with a short replication time and a rapid growth rate. Prognostic factors for SCLC in clinical practice are scarce. Retrospective analysis of 8‐year exten
Externí odkaz:
https://doaj.org/article/dc87d84e137a4e5faa95d8bc9dd2008d